Exact Mass: 474.1809056
Exact Mass Matches: 474.1809056
Found 500 metabolites which its exact mass value is equals to given mass value 474.1809056
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Sildenafil
C22H30N6O4S (474.20491400000003)
Sildenafil is a drug used to treat male erectile dysfunction (impotence) and pulmonary arterial hypertension (PAH), developed by the pharmaceutical company Pfizer. It was initially studied for use in hypertension (high blood pressure) and angina pectoris (a form of ischaemic cardiovascular disease). Phase I clinical trials under the direction of Ian Osterloh suggested that the drug had little effect on angina, but that it could induce marked penile erections; Sildenafil is a potent and selective inhibitor of cGMP specific phosphodiesterase type 5 (PDE5) which is responsible for degradation of cGMP in the corpus cavernosum. The molecular structure of sildenafil is similar to that of cGMP and acts as a competitive binding agent of PDE5 in the corpus cavernosum, resulting in more cGMP and better erections. Without sexual stimulation, and therefore lack of activation of the NO/cGMP system, sildenafil should not cause an erection. Other drugs that operate by the same mechanism include tadalafil (Cialis) and vardenafil (Levitra); Sildenafil citrate, sold under the names Viagra, Revatio and generically under various other names, is a drug used to treat male erectile dysfunction (impotence) and pulmonary arterial hypertension (PAH), developed by the pharmaceutical company Pfizer. Viagra pills are blue and diamond-shaped with the words Pfizer on one side, and VGR xx (where xx stands for 25, 50 or 100, the dose of that pill in milligrams) on the other. Its primary competitors on the market are tadalafil (Cialis), and vardenafil (Levitra). Sildenafil is a drug used to treat male erectile dysfunction (impotence) and pulmonary arterial hypertension (PAH), developed by the pharmaceutical company Pfizer. G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
Quinapril hydrochloride
D004791 - Enzyme Inhibitors > D011480 - Protease Inhibitors > D000806 - Angiotensin-Converting Enzyme Inhibitors C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent C471 - Enzyme Inhibitor > C783 - Protease Inhibitor > C247 - ACE Inhibitor D002317 - Cardiovascular Agents > D000959 - Antihypertensive Agents
alpha-D-Xylopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->4)-D-glucose
Constituent in cell wall polysaccharide of immature barley plants. Isolated from the enzymatic hydrolysates of tamarind polysaccharide. alpha-D-Xylopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->4)-D-glucose is found in cereals and cereal products and fruits. alpha-D-Xylopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->4)-D-glucose is found in cereals and cereal products. Constituent in cell wall polysaccharide of immature barley plants. It is isolated from the enzymatic hydrolysates of tamarind polysaccharide.
D-Galactopyranosyl-(1->3)-D-galactopyranosyl-(1->3)-L-arabinose
D-Galactopyranosyl-(1->3)-D-galactopyranosyl-(1->3)-L-arabinose is found in fruits. D-Galactopyranosyl-(1->3)-D-galactopyranosyl-(1->3)-L-arabinose is isolated from the hydrolysate of the gum of Spondias dulcis (ambarella). Isolated from the hydrolysate of the gum of Spondias dulcis (ambarella). D-Galactopyranosyl-(1->3)-D-galactopyranosyl-(1->3)-L-arabinose is found in fruits.
6-Feruloylglucose 2,3,4-trihydroxy-3-methylbutylglycoside
6-Feruloylglucose 2,3,4-trihydroxy-3-methylbutylglycoside is found in herbs and spices. 6-Feruloylglucose 2,3,4-trihydroxy-3-methylbutylglycoside is a constituent of sage (Salvia officinalis) leaf. Constituent of sage (Salvia officinalis) leaf [DFC]. 6-Feruloylglucose 2,3,4-trihydroxy-3-methylbutylglycoside is found in herbs and spices.
a-L-Arabinofuranosyl-(1->2)-[a-D-mannopyranosyl-(1->6)]-D-mannose
Residue present in tomato oligosaccharides. a-L-Arabinofuranosyl-(1->2)-[a-D-mannopyranosyl-(1->6)]-D-mannose is found in garden tomato. a-L-Arabinofuranosyl-(1->2)-[a-D-mannopyranosyl-(1->6)]-D-mannose is found in garden tomato. Residue present in tomato oligosaccharides.
Enterolactone 3'-glucuronide
C24H26O10 (474.15258960000006)
Enterolactone 3-glucuronide is a lignan metabolite produced in the liver. Enterolactone glucuronide is a potential urinary biomarker of whole grain intake (PMID: 23307617).
Enterolactone 3'-glucuronide
C24H26O10 (474.15258960000006)
Enterolactone 3-glucuronide is a lignan metabolite produced in the liver. Enterolactone glucuronide is a potential urinary biomarker of whole grain intake (PMID: 23307617).
N-[2-(Diacetylamino)-3-(4-isothiocyanatophenyl)propyl]-N-[2-(diacetylamino)propyl]acetamide
2-((2'-(5-Ethyl-3,4-diphenyl-1H-pyrazol-1-yl)-[1,1'-biphenyl]-3-yl)oxy)acetic acid
C31H26N2O3 (474.19433260000005)
BMS-309403 is a potent, orally active and selective adipocyte fatty acid binding protein (also known as FABP4, aP2) inhibitor with Kis of <2, 250, and 350 nM for FABP4, FABP3, and FABP5, respectively. BMS-309403 interacts with the fatty-acid-binding pocket within the interior of the protein and competitively inhibits the binding of endogenous fatty acids. BMS-309403 improves endothelial function in apolipoprotein E-deficient mice and in cultured human endothelial cells[1][2][3].
Ibrutinib metabolite M37
C25H26N6O4 (474.20154360000004)
MeOSuc-AAPA-CMK
Mitopodozidum
N-(2-Benzyl-3-((2-amino-4-methylpentyl)dithio)-1-oxopropyl)glycine benzyl ester
5alpha,6beta,8alpha-Trihydroxy-28-norisotoonafolin
4,5-Dihydro-11,5-dihydroxy-4-methoxytephrosin
C24H26O10 (474.15258960000006)
A member of the class of rotenones that is 4,5-dihydrotephrosin substituted by hydroxy groups at positions 11 and 5 and a methoxy group at position 4. It is isolated from the stems of Tephrosia toxicaria and exhibits antineoplastic activity.
9beta-Acetoxy-9beta-(5-acetoxy-tiglinoyloxy)-2-oxo-ludartin
C24H26O10 (474.15258960000006)
(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-[4-prop-2-enyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenoxy]oxane-3,4,5-triol
1-[3-methoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]ethanone
[(4R,6aR,9S,9aR,9bR)-9-methyl-3,6-dimethylidene-2,8-dioxo-3a,4,5,6a,7,9,9a,9b-octahydroazuleno[4,5-b]furan-4-yl] (E)-4-hydroxy-2-[[(E)-4-hydroxy-2-methylbut-2-enoyl]oxymethyl]but-2-enoate
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(2-hydroxy-4-prop-2-enylphenoxy)oxan-2-yl]methoxy]oxane-3,4,5-triol
(+)-(7S,8R,8R)-4,4,9-trihydroxy-3,5-dimethoxy-9-(5-hydroxy-4-oxo-pentanoyl)-2,7-cyclolignane|clemomanshurinane B
2-phenylpropionyl 6-O-beta-D-glucopyranosyl-beta-D-glucopyranoside
6-O-acetyl-2-O-(Z)-p-coumaroylsalicin
C24H26O10 (474.15258960000006)
4-(3-hydroxyprop-1-enyl)-2-methoxyphenyl 6-O-D-apio-beta-D-furanosyl-beta-D-glucopyranoside|coniferyl alcohol 4-O-beta-D-apiofuranosyl-(1->6)-beta-D-glucopyranoside|ligusinenoside A
7,8-trans-8,8-trans-7,8-trans-7,7-bis(5-methoxy-3,4-methylenedioxyphenyl)-8-acetoxymethyl-8-hydroxymethyltetrahydrofuran
C24H26O10 (474.15258960000006)
ligustrin-<4-hydroxy-5-(4,5-dihydroxytigloyloxy)-tiglate>|ligustrin-[4-hydroxy-5-(4,5-dihydroxytigloyloxy)-tiglate]
(+)-(7S,8R,8R)-4,4,9-trihydroxy-3,5-dimethoxy-9-(5-hydroxy-4-oxo-pentanoyl)-2,7-cyclolignane|clemomanshurinane A
(1RS,2SR)-1,2-dihydro-7-hydroxy-1-(4-hydroxy-3,5-dimethoxyphenyl)-6,8-dimethoxynaphthalene-2,3-dicarboxylic acid dimethyl ester|dimethyl (?)-thomasidioate|thomasidioic acid dimethyl ester|trans-thomasidioic acid dimethyl ester
C24H26O10 (474.15258960000006)
NSC 72274; Podophyllic acid ethylhydrazide; Podophyllinic acid 2-ethylhydrazide
(2R)-2-[(4-hydroxyphenyl)methyl]-3-[4-methoxy-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]-2H-furan-5-one
C24H26O10 (474.15258960000006)
8beta-5-(4,5-dihydroxytigloyl)-4-hydroxytigloyloxydesacetylzuubergenin|8beta-5-<4,5-dihydroxytigloyl>-4-hydroxytigloyloxydesacetylzuubergenin
1-(4-beta-D-glucopyranosyloxybenzyl)-2-isobutyltartrate|coelovirin A
alpha-L-Araf-(1 -> 4)-beta-D-Galp-(1 -> 6)-alphabeta-D-Galp
O-beta-D-Galactopyranosyl-(1->3)-O-beta-D-galactopyranosyl-(1->4)-D-xylose
ligustrin-4-hydroxy-5-(2-1,2-dihydroxyacryloyl)-tiglate
2-(benzoyloxymethyl)phenyl (3,6-di-O-acetyl)-beta-D-glucopyranoside
C24H26O10 (474.15258960000006)
2-(3,4-dihydroxy-4-hydroxymethyltetrahydrofuran-2-yl-oxymethyl)-6-[3-(4-hydroxy-3-methoxyphenyl)allyloxy]tetrahydropyran-3,4,5-triol|coniferyl 9-O-[beta-D-apiofuranosyl(1->6)]-O-beta-D-glucopyranoside
benzoic acid methyl ester 4-O-(3-O-methyl-alpha-L-rhamnopyranosyl)-(1->2)-beta-D-allopyranoside|keteleeroside C
10-beta-D-glucopyranosyloxy-3,9-dimethoxy-7-methoxymethyl-5H-dibenzo[a,c][7]annulene|subavenoside E
lobarin
A member of the class of 2-benzofurans that is 3-butyl-3-hydroxy-2-benzofuran-1(3H)-one substituted by a 3-carboxy-4,6-dihydroxy-2-pentylphenoxy group and a methoxy group at positions 4 and 6, respectively. It is a metabolite isolated from the Sumatran lichen, Stereocaulon halei.
dimethyl (E,E)-4,4?-dihydroxy-3,3?,5,5?-tetramethoxylign-7,7?-dien-9,9?-dioate
C24H26O10 (474.15258960000006)
3-methoxy-4-O-beta-D-apiofuranosyl-(1?2)-beta-D-glucopyranosylpropiophenone
3-methoxy-4-O-beta-D-apiofuranosyl-(1?6)-beta-D-glucopyranosylpropiophenone
1-O-isopropyl-[5-O-(4-hydroxybenzoyl)-beta-D-apiofuranosyl]-(1?2)-beta-D-glucopyranoside|clausenoside A
desacetoxyzuubergenin-8beta-4-hydroxy-5-(1,2-dihydroxyethylacryloyl)-tiglate
4-(4-beta-D-glucopyranosyloxybenzyl)-2-isobutyltartrate|coelovirin B
junipercomnoside E|trans-coniferyl alcohol 9-O-(6-O-alpha-L-arabinofuranosyl)-beta-D-glucopyranoside
3alpha,4alpha-epoxyligustrin-4-hydroxy-5-(4-hydroxytigloyl)-tiglate
8alpha-(5-acetoxysenecioyloxy)-3-oxo-1-desoxy-1,2-dehydrohirsutinolide-13-O-acetate
C24H26O10 (474.15258960000006)
6-O-beta-D-glucopyranosyl-2-O-(2-phenylpropionyl)-D-glucose
Coniferin 2-O-beta-D-apiofuranoside|coniferyl alcohol 4-O-beta-apiofuranosyl-(1->2)-beta-glucopyranoside|coniferylalcohol-4-O-2)>glucoside
O-beta-D-Galactopyranosyl-(1 - > 6)-O-beta-D-galactopyranosyl-(1 - > 3)-L-arabinose|O3-(O6-beta-D-Galactopyranosyl-beta-D-galactopyranosyl)-L-arabinose
(aS,5S,6S,7S)-5,6,7,8-tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethyl-5-[Ac]oxybenzo[3,4]cycloocta[1,2-f][1,3]benzodioxol-6-ol|schisanwilsonin F
Asn Val Gln Asp
C18H30N6O9 (474.20741699999996)
C21H30O12_beta-D-Glucopyranoside, 2-hydroxy-4-(2-propen-1-yl)phenyl 6-O-beta-D-glucopyranosyl
C21H30O12_4-Allyl-2-(beta-D-glucopyranosyloxy)phenyl beta-D-glucopyranoside
C25H30O9_(4R,6aR,9S,9aR,9bR)-9-Methyl-3,6-bis(methylene)-2,8-dioxododecahydroazuleno[4,5-b]furan-4-yl (2E)-4-hydroxy-2-({[(2E)-4-hydroxy-2-methyl-2-butenoyl]oxy}methyl)-2-butenoate
C21H30O12_4-Acetyl-2-methoxyphenyl 6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranoside
sildenafil
C22H30N6O4S (474.20491400000003)
G - Genito urinary system and sex hormones > G04 - Urologicals > G04B - Urologicals > G04BE - Drugs used in erectile dysfunction D004791 - Enzyme Inhibitors > D010726 - Phosphodiesterase Inhibitors > D058986 - Phosphodiesterase 5 Inhibitors C471 - Enzyme Inhibitor > C744 - Phosphodiesterase Inhibitor > C2127 - cGMP Phosphodiesterase Inhibitor COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78274 - Agent Affecting Cardiovascular System > C29707 - Vasodilating Agent D000089162 - Genitourinary Agents > D064804 - Urological Agents D002317 - Cardiovascular Agents > D014665 - Vasodilator Agents Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS
(2R,3S,4S,5R,6R)-2-(hydroxymethyl)-6-[[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(2-hydroxy-4-prop-2-enylphenoxy)oxan-2-yl]methoxy]oxane-3,4,5-triol_major
1-[3-methoxy-4-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-[[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxyphenyl]ethanone_major
Ala Glu Gln Gln
C18H30N6O9 (474.20741699999996)
Ala Gln Glu Gln
C18H30N6O9 (474.20741699999996)
Ala Gln Gln Glu
C18H30N6O9 (474.20741699999996)
Cys Cys His Ile
Cys Cys His Leu
Cys Cys Ile His
Cys Cys Leu His
Cys Asp His Thr
C17H26N6O8S (474.15327560000003)
Cys Asp Thr His
C17H26N6O8S (474.15327560000003)
Cys Glu His Ser
C17H26N6O8S (474.15327560000003)
Cys Glu Ser His
C17H26N6O8S (474.15327560000003)
Cys His Cys Ile
Cys His Cys Leu
Cys His Asp Thr
C17H26N6O8S (474.15327560000003)
Cys His Glu Ser
C17H26N6O8S (474.15327560000003)
Cys His Ile Cys
Cys His Leu Cys
Cys His Ser Glu
C17H26N6O8S (474.15327560000003)
Cys His Thr Asp
C17H26N6O8S (474.15327560000003)
Cys Ile Cys His
Cys Ile His Cys
Cys Leu Cys His
Cys Leu His Cys
Cys Pro Gln Gln
Cys Gln Pro Gln
Cys Gln Gln Pro
Cys Ser Glu His
C17H26N6O8S (474.15327560000003)
Cys Ser His Glu
C17H26N6O8S (474.15327560000003)
Cys Thr Asp His
C17H26N6O8S (474.15327560000003)
Cys Thr His Asp
C17H26N6O8S (474.15327560000003)
Asp Cys His Thr
C17H26N6O8S (474.15327560000003)
Asp Cys Thr His
C17H26N6O8S (474.15327560000003)
Asp Asp Glu Pro
C18H26N4O11 (474.15980060000004)
Asp Asp Pro Glu
C18H26N4O11 (474.15980060000004)
Asp Glu Asp Pro
C18H26N4O11 (474.15980060000004)
Asp Glu Pro Asp
C18H26N4O11 (474.15980060000004)
Asp Phe Gly His
Asp Phe His Gly
Asp Gly Phe His
Asp Gly His Phe
Asp His Cys Thr
C17H26N6O8S (474.15327560000003)
Asp His Phe Gly
Asp His Gly Phe
Asp His Thr Cys
C17H26N6O8S (474.15327560000003)
Asp Ile Asn Asn
C18H30N6O9 (474.20741699999996)
Asp Leu Asn Asn
C18H30N6O9 (474.20741699999996)
Asp Asn Ile Asn
C18H30N6O9 (474.20741699999996)
Asp Asn Leu Asn
C18H30N6O9 (474.20741699999996)
Asp Asn Asn Ile
C18H30N6O9 (474.20741699999996)
Asp Asn Asn Leu
C18H30N6O9 (474.20741699999996)
Asp Asn Gln Val
C18H30N6O9 (474.20741699999996)
Asp Asn Val Gln
C18H30N6O9 (474.20741699999996)
Asp Pro Asp Glu
C18H26N4O11 (474.15980060000004)
Asp Pro Glu Asp
C18H26N4O11 (474.15980060000004)
Asp Gln Asn Val
C18H30N6O9 (474.20741699999996)
Asp Gln Val Asn
C18H30N6O9 (474.20741699999996)
Asp Thr Cys His
C17H26N6O8S (474.15327560000003)
Asp Thr His Cys
C17H26N6O8S (474.15327560000003)
Asp Val Asn Gln
C18H30N6O9 (474.20741699999996)
Asp Val Gln Asn
C18H30N6O9 (474.20741699999996)
Glu Ala Gln Gln
C18H30N6O9 (474.20741699999996)
Glu Cys His Ser
C17H26N6O8S (474.15327560000003)
Glu Cys Ser His
C17H26N6O8S (474.15327560000003)
Glu Asp Asp Pro
C18H26N4O11 (474.15980060000004)
Glu Asp Pro Asp
C18H26N4O11 (474.15980060000004)
Glu Glu Pro Thr
Glu Glu Thr Pro
Glu His Cys Ser
C17H26N6O8S (474.15327560000003)
Glu His Ser Cys
C17H26N6O8S (474.15327560000003)
Glu Asn Asn Val
C18H30N6O9 (474.20741699999996)
Glu Asn Val Asn
C18H30N6O9 (474.20741699999996)
Glu Pro Asp Asp
C18H26N4O11 (474.15980060000004)
Glu Pro Glu Thr
Glu Pro Thr Glu
Glu Gln Ala Gln
C18H30N6O9 (474.20741699999996)
Glu Gln Gln Ala
C18H30N6O9 (474.20741699999996)
Glu Ser Cys His
C17H26N6O8S (474.15327560000003)
Glu Ser His Cys
C17H26N6O8S (474.15327560000003)
Glu Thr Glu Pro
Glu Thr Pro Glu
Glu Val Asn Asn
C18H30N6O9 (474.20741699999996)
Phe Asp Gly His
Phe Asp His Gly
Phe Gly Asp His
Phe Gly His Asp
Phe His Asp Gly
Phe His Gly Asp
Gly Asp Phe His
Gly Asp His Phe
Gly Phe Asp His
Gly Phe His Asp
Gly His Asp Phe
Gly His Phe Asp
Gly His Met Met
Gly Met His Met
Gly Met Met His
His Cys Cys Ile
His Cys Cys Leu
His Cys Asp Thr
C17H26N6O8S (474.15327560000003)
His Cys Glu Ser
C17H26N6O8S (474.15327560000003)
His Cys Ile Cys
His Cys Leu Cys
His Cys Ser Glu
C17H26N6O8S (474.15327560000003)
His Cys Thr Asp
C17H26N6O8S (474.15327560000003)
His Asp Cys Thr
C17H26N6O8S (474.15327560000003)
His Asp Phe Gly
His Asp Gly Phe
His Asp Thr Cys
C17H26N6O8S (474.15327560000003)
His Glu Cys Ser
C17H26N6O8S (474.15327560000003)
His Glu Ser Cys
C17H26N6O8S (474.15327560000003)
His Phe Asp Gly
His Phe Gly Asp
His Gly Asp Phe
His Gly Phe Asp
His Gly Met Met
His Ile Cys Cys
His Leu Cys Cys
His Met Gly Met
His Met Met Gly
His Met Ser Thr
His Met Thr Ser
His Ser Cys Glu
C17H26N6O8S (474.15327560000003)
His Ser Glu Cys
C17H26N6O8S (474.15327560000003)
His Ser Met Thr
His Ser Thr Met
His Thr Cys Asp
C17H26N6O8S (474.15327560000003)
His Thr Asp Cys
C17H26N6O8S (474.15327560000003)
His Thr Met Ser
His Thr Ser Met
Ile Cys Cys His
Ile Cys His Cys
Ile Asp Asn Asn
C18H30N6O9 (474.20741699999996)
Ile His Cys Cys
Ile Asn Asp Asn
C18H30N6O9 (474.20741699999996)
Ile Asn Asn Asp
C18H30N6O9 (474.20741699999996)
Leu Cys Cys His
Leu Cys His Cys
Leu Asp Asn Asn
C18H30N6O9 (474.20741699999996)
Leu His Cys Cys
Leu Asn Asp Asn
C18H30N6O9 (474.20741699999996)
Leu Asn Asn Asp
C18H30N6O9 (474.20741699999996)
Met Gly His Met
Met Gly Met His
Met His Gly Met
Met His Met Gly
Met His Ser Thr
Met His Thr Ser
Met Met Gly His
Met Met His Gly
Met Met Pro Pro
Met Asn Asn Pro
Met Asn Pro Asn
Met Pro Met Pro
Met Pro Asn Asn
Met Pro Pro Met
Met Ser His Thr
Met Ser Thr His
Met Thr His Ser
Met Thr Ser His
Asn Asp Ile Asn
C18H30N6O9 (474.20741699999996)
Asn Asp Leu Asn
C18H30N6O9 (474.20741699999996)
Asn Asp Asn Ile
C18H30N6O9 (474.20741699999996)
Asn Asp Asn Leu
C18H30N6O9 (474.20741699999996)
Asn Asp Gln Val
C18H30N6O9 (474.20741699999996)
Asn Asp Val Gln
C18H30N6O9 (474.20741699999996)
Asn Glu Asn Val
C18H30N6O9 (474.20741699999996)
Asn Glu Val Asn
C18H30N6O9 (474.20741699999996)
Asn Ile Asp Asn
C18H30N6O9 (474.20741699999996)
Asn Ile Asn Asp
C18H30N6O9 (474.20741699999996)
Asn Leu Asp Asn
C18H30N6O9 (474.20741699999996)
Asn Leu Asn Asp
C18H30N6O9 (474.20741699999996)
Asn Met Asn Pro
Asn Met Pro Asn
Asn Asn Asp Ile
C18H30N6O9 (474.20741699999996)
Asn Asn Asp Leu
C18H30N6O9 (474.20741699999996)
Asn Asn Glu Val
C18H30N6O9 (474.20741699999996)
Asn Asn Ile Asp
C18H30N6O9 (474.20741699999996)
Asn Asn Leu Asp
C18H30N6O9 (474.20741699999996)
Asn Asn Met Pro
Asn Asn Asn Asn
C16H26N8O9 (474.18226660000005)
Asn Asn Pro Met
Asn Asn Val Glu
C18H30N6O9 (474.20741699999996)
Asn Pro Met Asn
Asn Pro Asn Met
Asn Gln Asp Val
C18H30N6O9 (474.20741699999996)
Asn Gln Val Asp
C18H30N6O9 (474.20741699999996)
Asn Val Asp Gln
C18H30N6O9 (474.20741699999996)
Asn Val Glu Asn
C18H30N6O9 (474.20741699999996)
Asn Val Asn Glu
C18H30N6O9 (474.20741699999996)
Pro Cys Gln Gln
Pro Asp Asp Glu
C18H26N4O11 (474.15980060000004)
Pro Asp Glu Asp
C18H26N4O11 (474.15980060000004)
Pro Glu Asp Asp
C18H26N4O11 (474.15980060000004)
Pro Glu Glu Thr
Pro Glu Thr Glu
Pro Met Met Pro
Pro Met Asn Asn
Pro Met Pro Met
Pro Asn Met Asn
Pro Asn Asn Met
Pro Pro Met Met
Pro Gln Cys Gln
Pro Gln Gln Cys
Pro Thr Glu Glu
Gln Ala Glu Gln
C18H30N6O9 (474.20741699999996)
Gln Ala Gln Glu
C18H30N6O9 (474.20741699999996)
Gln Cys Pro Gln
Gln Cys Gln Pro
Gln Asp Asn Val
C18H30N6O9 (474.20741699999996)
Gln Asp Val Asn
C18H30N6O9 (474.20741699999996)
Gln Glu Ala Gln
C18H30N6O9 (474.20741699999996)
Gln Glu Gln Ala
C18H30N6O9 (474.20741699999996)
Gln Asn Asp Val
C18H30N6O9 (474.20741699999996)
Gln Asn Val Asp
C18H30N6O9 (474.20741699999996)
Gln Pro Cys Gln
Gln Pro Gln Cys
Gln Gln Ala Glu
C18H30N6O9 (474.20741699999996)
Gln Gln Cys Pro
Gln Gln Glu Ala
C18H30N6O9 (474.20741699999996)
Gln Gln Pro Cys
Gln Val Asp Asn
C18H30N6O9 (474.20741699999996)
Gln Val Asn Asp
C18H30N6O9 (474.20741699999996)
Ser Cys Glu His
C17H26N6O8S (474.15327560000003)
Ser Cys His Glu
C17H26N6O8S (474.15327560000003)
Ser Glu Cys His
C17H26N6O8S (474.15327560000003)
Ser Glu His Cys
C17H26N6O8S (474.15327560000003)
Ser His Cys Glu
C17H26N6O8S (474.15327560000003)
Ser His Glu Cys
C17H26N6O8S (474.15327560000003)
Ser His Met Thr
Ser His Thr Met
Ser Met His Thr
Ser Met Thr His
Ser Thr His Met
Ser Thr Met His
Thr Cys Asp His
C17H26N6O8S (474.15327560000003)
Thr Cys His Asp
C17H26N6O8S (474.15327560000003)
Thr Asp Cys His
C17H26N6O8S (474.15327560000003)
Thr Asp His Cys
C17H26N6O8S (474.15327560000003)
Thr Glu Glu Pro
Thr Glu Pro Glu
Thr His Cys Asp
C17H26N6O8S (474.15327560000003)
Thr His Asp Cys
C17H26N6O8S (474.15327560000003)
Thr His Met Ser
Thr His Ser Met
Thr Met His Ser
Thr Met Ser His
Thr Pro Glu Glu
Thr Ser His Met
Thr Ser Met His
Val Asp Asn Gln
C18H30N6O9 (474.20741699999996)
Val Asp Gln Asn
C18H30N6O9 (474.20741699999996)
Val Glu Asn Asn
C18H30N6O9 (474.20741699999996)
Val Asn Asp Gln
C18H30N6O9 (474.20741699999996)
Val Asn Glu Asn
C18H30N6O9 (474.20741699999996)
Val Asn Asn Glu
C18H30N6O9 (474.20741699999996)
Val Asn Gln Asp
C18H30N6O9 (474.20741699999996)
Val Gln Asp Asn
C18H30N6O9 (474.20741699999996)
Val Gln Asn Asp
C18H30N6O9 (474.20741699999996)
Luteolin 7,3-dimethyl ether 5-glucoside
C24H26O10 (474.15258960000006)
6-Feruloylglucose 2,3,4-trihydroxy-3-methylbutylglycoside
D-Galactopyranosyl-(1->3)-D-galactopyranosyl-(1->3)-L-arabinose
alpha-D-Xylopyranosyl-(1->6)-beta-D-glucopyranosyl-(1->4)-D-glucose
a-L-Arabinofuranosyl-(1->2)-[a-D-mannopyranosyl-(1->6)]-D-mannose
4-Acetyl-2-methoxyphenyl 6-O-(6-deoxy-?-L-mannopyranosyl)-?-D-glucopyranoside
(4R,6aR,9S,9aR,9bR)-9-Methyl-3,6-bis(methylene)-2,8-dioxododecahydroazuleno[4,5-b]furan-4-yl (2E)-4-hydroxy-2-({[(2E)-4-hydroxy-2-methyl-2-butenoyl]oxy}methyl)-2-butenoate
ETHYL 4-(2,4-BIS(BENZYLOXY)-5-ISOPROPYLPHENYL)-2-HYDROXY-4-OXOBUT-2-ENOATE
butyl prop-2-enoate,2-methylprop-2-enoic acid,2-methyl-2-(prop-2-enoylamino)propane-1-sulfonic acid,prop-2-enenitrile
C21H34N2O8S (474.20357640000003)
N-[2-(4-{[4-(Cyclobutylamino)-5-(trifluoromethyl)-2-pyrimidinyl]amino}-11-azatricyclo[6.2.1.02,7]undeca-2,4,6-trien-11-yl)-2-oxoethyl]acetamide
C23H25F3N6O2 (474.19909859999996)
[9,10-Di(1-naphthyl)-2-anthryl]boronic acid
C34H23BO2 (474.17910079999996)
TRIMETHYL((4-((4-((4-(PHENYLETHYNYL)PHENYL)ETHYNYL)PHENYL)ETHYNYL)PHENYL)ETHYNYL)SILANE
(R)-4-((((9H-FLUOREN-9-YL)METHOXY)CARBONYL)AMINO)-2-(((BENZYLOXY)CARBONYL)AMINO)BUTANOIC ACID
Picloxydine
S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives C254 - Anti-Infective Agent > C28394 - Topical Anti-Infective Agent
MITOPODOZIDE
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C274 - Antineoplastic Agent > C1931 - Antineoplastic Plant Product > C1331 - Epipodophyllotoxin Compound C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor D000970 - Antineoplastic Agents C1907 - Drug, Natural Product
pf-03814735
C23H25F3N6O2 (474.19909859999996)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
flecainide acetate
C19H24F6N2O5 (474.15893259999996)
D002317 - Cardiovascular Agents > D026941 - Sodium Channel Blockers > D061567 - Voltage-Gated Sodium Channel Blockers C78274 - Agent Affecting Cardiovascular System > C47793 - Antiarrhythmic Agent D002317 - Cardiovascular Agents > D000889 - Anti-Arrhythmia Agents D049990 - Membrane Transport Modulators C93038 - Cation Channel Blocker
ZD 7155 hydrochloride
ZD 7155 hydrochloride is an angiotensin II receptor type 1 (AT1 receptor) antagonist.
methyl 1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazole-[3,4-c]pyridine-3-carboxylate
C26H26N4O5 (474.19031060000003)
[9,10-Di(2-naphthyl)-2-anthryl]boronic acid
C34H23BO2 (474.17910079999996)
benzene-1,3-dicarboxylic acid,furan-2,5-dione,3-(3-hydroxypropoxy)propan-1-ol,propane-1,2-diol
Fosmetpantotenate
C20H31N2O9P (474.17670860000004)
C307 - Biological Agent > C29726 - Enzyme Replacement or Supplement Agent
[(3R,4R)-3-[(4-hydroxybenzoyl)amino]azepan-4-yl] 4-(2-hydroxybenzoyl)benzoate
Keoxifene
C28H28NO4S+ (474.1738948000001)
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D020847 - Estrogen Receptor Modulators D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists > D004965 - Estrogen Antagonists D050071 - Bone Density Conservation Agents
alpha-D-xylosyl-(1->6)-beta-D-glucosyl-(1->4)-beta-D-glucose
Ananolignan D
A lignan with a dibenzocyclooctadiene skeleton isolated from Kadsura ananosma.
Ananolignan E
A lignan with a dibenzocyclooctadiene skeleton isolated from Kadsura ananosma.
MSACK
D009676 - Noxae > D000477 - Alkylating Agents > D000590 - Amino Acid Chloromethyl Ketones
(3aS,4R,9bR)-N-(2,5-difluorophenyl)-4-(hydroxymethyl)-5-methyl-8-[2-(3-pyridinyl)ethynyl]-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinoline-1-carboxamide
alpha-D-mannosyl-(1->6)-[beta-D-xylosyl-(1->2)]-beta-D-mannose
alpha-L-arabinosyl-(1->3)-beta-D-galactosyl-(1->6)-D-galactose
(1S,9R,10R,11R)-N-(1,3-benzodioxol-5-ylmethyl)-10-(hydroxymethyl)-6-oxo-12-(pyridin-3-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C26H26N4O5 (474.19031060000003)
1-(4-chlorophenyl)-3-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[[(4R,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
1-(3-chlorophenyl)-3-[(4S,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-chlorophenyl)-3-[(5R,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-chlorophenyl)-3-[(5S,6S,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
N-[(2R,3S,6S)-6-[2-(4-benzyltriazol-1-yl)ethyl]-2-(hydroxymethyl)oxan-3-yl]-2-fluorobenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
1-(2-chlorophenyl)-3-[(5R,6S,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4R,7R,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
2-fluoro-N-[(2S,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
2-fluoro-N-[(2R,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
2-fluoro-N-[(2R,3R,6S)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
(1R,9S,10S,11S)-N-(1,3-benzodioxol-5-ylmethyl)-10-(hydroxymethyl)-6-oxo-12-(pyridin-3-ylmethyl)-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxamide
C26H26N4O5 (474.19031060000003)
(2R,3R,3aS,9bS)-3-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-6-oxo-N-phenyl-7-(3-pyridinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C26H26N4O5 (474.19031060000003)
methyl (1R,9S,10S,11S)-12-[(2-fluorophenyl)methyl]-10-(hydroxymethyl)-6-oxo-5-[(E)-2-phenylethenyl]-7,12-diazatricyclo[7.2.1.02,7]dodeca-2,4-diene-11-carboxylate
N-[[(4S,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
N-[[(4R,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
1-(4-chlorophenyl)-3-[(4S,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-chlorophenyl)-3-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
2-fluoro-N-[(2S,3S,6S)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
2-fluoro-N-[(2S,3S,6R)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2R,3S,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2R,3R,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2S,3S,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C26H26N4O5 (474.19031060000003)
N-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C26H26N4O5 (474.19031060000003)
2-[(2R,4aS,12aS)-8-[[(3,5-difluorophenyl)-oxomethyl]amino]-5-methyl-6-oxo-2,3,4,4a,12,12a-hexahydropyrano[2,3-c][1,5]benzoxazocin-2-yl]acetic acid methyl ester
(2S,3S,3aR,9bR)-3-(hydroxymethyl)-1-(2-methoxy-1-oxoethyl)-6-oxo-N-phenyl-7-(3-pyridinyl)-3,3a,4,9b-tetrahydro-2H-pyrrolo[2,3-a]indolizine-2-carboxamide
C26H26N4O5 (474.19031060000003)
N-[[(4R,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
N-[[(4S,5S)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
N-[[(4S,5S)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
N-[[(4R,5R)-2-[(2R)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
N-[[(4S,5R)-2-[(2S)-1-hydroxypropan-2-yl]-4-methyl-1,1-dioxo-8-[(E)-prop-1-enyl]-4,5-dihydro-3H-6,1lambda6,2-benzoxathiazocin-5-yl]methyl]-N-methylpyrazine-2-carboxamide
1-(2-chlorophenyl)-3-[(5S,6R,9S)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(2-chlorophenyl)-3-[(5R,6R,9R)-5-methoxy-3,6,9-trimethyl-2-oxo-11-oxa-3,8-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4S,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(3-chlorophenyl)-3-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-chlorophenyl)-3-[(4S,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-chlorophenyl)-3-[(4R,7R,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-chlorophenyl)-3-[(4R,7S,8S)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
1-(4-chlorophenyl)-3-[(4R,7S,8R)-8-methoxy-4,7,10-trimethyl-11-oxo-2-oxa-5,10-diazabicyclo[10.4.0]hexadeca-1(12),13,15-trien-14-yl]urea
2-fluoro-N-[(2R,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
2-fluoro-N-[(2S,3R,6R)-2-(hydroxymethyl)-6-[2-[4-(phenylmethyl)-1-triazolyl]ethyl]-3-oxanyl]benzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2S,3R,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2S,3S,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2S,3R,6R)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2R,3S,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-[(2R,3R,6S)-6-[2-[4-(4-fluorophenyl)-1-triazolyl]ethyl]-2-(hydroxymethyl)-3-oxanyl]-2-methylbenzenesulfonamide
C23H27FN4O4S (474.17369540000004)
N-(2,3-dihydro-1H-inden-2-yl)-2-[(2S,5R,6S)-6-(hydroxymethyl)-5-[(3-methoxyphenyl)sulfonylamino]-2-oxanyl]acetamide
N-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C26H26N4O5 (474.19031060000003)
N-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C26H26N4O5 (474.19031060000003)
N-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C26H26N4O5 (474.19031060000003)
N-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C26H26N4O5 (474.19031060000003)
N-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-3-[2-oxo-2-(pyridin-4-ylmethylamino)ethyl]-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-6-yl]-3-pyridinecarboxamide
C26H26N4O5 (474.19031060000003)
(1R,5S)-N-(3-chlorophenyl)-7-[4-[3-[dimethylamino(oxo)methyl]phenyl]phenyl]-3,6-diazabicyclo[3.1.1]heptane-6-carboxamide
[(4R,6aR,9S,9aR,9bR)-9-methyl-3,6-dimethylidene-2,8-dioxo-3a,4,5,6a,7,9,9a,9b-octahydroazuleno[4,5-b]furan-4-yl] (Z)-4-hydroxy-2-[[(E)-4-hydroxy-2-methylbut-2-enoyl]oxymethyl]but-2-enoate
N-[4-[[4-(3-cyanobenzoyl)piperazin-1-yl]methyl]phenyl]-4-methylbenzenesulfonamide
[2-Hydroxy-3-[hydroxy-(2,3,4,5,6-pentahydroxycyclohexyl)oxyphosphoryl]oxypropyl] nonanoate
C18H35O12P (474.18660400000005)
MX69
C27H26N2O4S (474.16131960000007)
MX69 is an inhibitor of MDM2/XIAP, used for cancer treatment.
(1s,2s,3s,4r,7s,14s,16s)-2-hydroxy-4-[(2s)-3-hydroxy-2,4-dimethyl-5-oxofuran-2-yl]-1,7,16-trimethyl-13,17-dioxatetracyclo[9.5.2.0³,¹⁴.0¹⁴,¹⁸]octadec-11(18)-ene-6,10,12-trione
(8r,9r,10s)-9-hydroxy-3,4,5,19-tetramethoxy-9,10-dimethyl-15,17-dioxatetracyclo[10.7.0.0²,⁷.0¹⁴,¹⁸]nonadeca-1(12),2(7),3,5,13,18-hexaen-8-yl acetate
9-methyl-3,6-dimethylidene-2-oxo-3ah,4h,5h,6ah,7h,9ah,9bh-azuleno[4,5-b]furan-4-yl 2-{[(3,4-dihydroxy-2-methylidenebutanoyl)oxy]methyl}-4-hydroxybut-2-enoate
(10r)-10-hydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-oxatricyclo[13.2.2.1³,⁷]icosa-1(17),3(20),4,6,15,18-hexaen-12-one
(2r,3r,4s,5r,6s)-4-{[(2s,3r,4r)-3,4-dihydroxy-4-(hydroxymethyl)oxolan-2-yl]oxy}-2-(hydroxymethyl)-6-{4-[(1e)-3-hydroxyprop-1-en-1-yl]-2-methoxyphenoxy}oxane-3,5-diol
(2e)-3-{[(3ar,4r,9as,9br)-6,9-dimethyl-3-methylidene-2-oxo-3ah,4h,5h,7h,9ah,9bh-azuleno[4,5-b]furan-4-yl]oxy}-2-(2-hydroxyethylidene)-3-oxopropyl (2e)-4-hydroxy-2-(hydroxymethyl)but-2-enoate
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxan-2-yl (2s)-2-phenylpropanoate
{[2-amino-1,4-dihydroxy-5-(c-hydroxycarbonimidoyloxy)pentylidene]amino}[3,4-dihydroxy-5-(5-methyl-2,4-dioxo-3h-pyridin-1-yl)oxolan-2-yl]acetic acid
C18H26N4O11 (474.15980060000004)